147 related articles for article (PubMed ID: 1610685)
1. HTLV-1-negative pleomorphic T-cell lymphoma of the skin: the clinicopathological correlations and natural history of 15 patients.
Sterry W; Siebel A; Mielke V
Br J Dermatol; 1992 May; 126(5):456-62. PubMed ID: 1610685
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma.
Beljaards RC; Meijer CJ; Van der Putte SC; Hollema H; Geerts ML; Bezemer PD; Willemze R
J Pathol; 1994 Jan; 172(1):53-60. PubMed ID: 7931828
[TBL] [Abstract][Full Text] [Related]
3. Pleomorphic T-cell lymphoma and large-cell anaplastic lymphoma of the skin. A morphological, immunophenotypical, and ultrastructural study of two typical cases.
Sterry W; Korte B; Schubert C
Am J Dermatopathol; 1989 Apr; 11(2):112-23. PubMed ID: 2653081
[TBL] [Abstract][Full Text] [Related]
4. Intraepidermal localization of the clone in cutaneous T-cell lymphoma.
Bagot M; Wechsler J; Lescs MC; Revuz J; Farcet JP; Gaulard P
J Am Acad Dermatol; 1992 Oct; 27(4):589-93. PubMed ID: 1357011
[TBL] [Abstract][Full Text] [Related]
5. A case of Sézary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30-positive large-cell pleomorphic lymphoma.
Carrozza PM; Kempf W; Kazakov DV; Dummer R; Burg G
Br J Dermatol; 2002 Sep; 147(3):582-6. PubMed ID: 12207606
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin lymphoma of the skin excluding mycosis fungoides and cutaneous involvement of adult T-cell leukemia/lymphoma.
Mukai K; Sato Y; Watanabe S; Ishihara K; Shimoyama M; Shimosato Y
J Cutan Pathol; 1988 Aug; 15(4):193-200. PubMed ID: 3263403
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
8. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
9. The spectrum of cutaneous lymphomas in patients less than 20 years of age.
Fink-Puches R; Chott A; Ardigó M; Simonitsch I; Ferrara G; Kerl H; Cerroni L
Pediatr Dermatol; 2004; 21(5):525-33. PubMed ID: 15461755
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous T-cell lymphomas.
Rosen ST; Querfeld C
Hematology Am Soc Hematol Educ Program; 2006; ():323-30, 513. PubMed ID: 17124079
[TBL] [Abstract][Full Text] [Related]
11. HTLV-1-associated cutaneous disease: a clinicopathological and molecular study of patients from the U.K.
Whittaker SJ; Ng YL; Rustin M; Levene G; McGibbon DH; Smith NP
Br J Dermatol; 1993 May; 128(5):483-92. PubMed ID: 8504037
[TBL] [Abstract][Full Text] [Related]
12. Relative frequency of the different types of cutaneous T cell and natural killer cell lymphomas in Korea based on the proposed WHO classification and the EORTC classification.
Chang SE; Jee MS; Kim KJ; Choi JH; Sung KJ; Moon KC; Koh JK
J Dermatol; 2003 Jan; 30(1):42-7. PubMed ID: 12598708
[TBL] [Abstract][Full Text] [Related]
13. FoxP3-positive T cell lymphoma arising in non-HTLV1 carrier: clinicopathological analysis of 11 cases of PTCL-NOS and 2 cases of mycosis fungoides.
Satou A; Asano N; Kato S; Katsuya H; Ishitsuka K; Elsayed AA; Nakamura S
Histopathology; 2016 Jun; 68(7):1099-108. PubMed ID: 26426838
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous T-cell lymphoma.
Schein PS; Macdonald JS; Edelson R
Cancer; 1976 Oct; 38(4):1859-61. PubMed ID: 1086709
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic studies in cutaneous T-cell lymphomas: clinical implications.
Ralfkiaer E; Wollf-Sneedorff A; Thomsen K; Vejlsgaard GL
Br J Dermatol; 1993 Dec; 129(6):655-9. PubMed ID: 8286247
[TBL] [Abstract][Full Text] [Related]
16. Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study.
Maurelli M; Tessari G; Colato C; Schena D; Girolomoni G
Eur J Dermatol; 2018 Feb; 28(1):44-49. PubMed ID: 29171395
[TBL] [Abstract][Full Text] [Related]
17. Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage.
Vonderheid EC; Diamond LW; van Vloten WA; Scheffer E; Meijer CJ; Cashell AW; Hardman JM; Lai SM; Hermans J; Matthews MJ
Cancer; 1994 Jan; 73(1):207-18. PubMed ID: 8275427
[TBL] [Abstract][Full Text] [Related]
18. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
19. Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.
Olsen EA
Dermatol Clin; 2015 Oct; 33(4):643-54. PubMed ID: 26433839
[TBL] [Abstract][Full Text] [Related]
20. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions.
Kempf W; Dummer R; Burg G
Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S84-93. PubMed ID: 9894473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]